Latest Housing News

Australian Finance Group used its 2026 AGM to highlight a stronger, less volume-dependent earnings base after statutory profit rose 39% in FY26. AFG Securities’ loan book has since reached $7.3 billion, while recent investments are expected to add $13 million to FY27 EBITDA under stated assumptions.

Fletcher Building has secured Fast Track approval to expand and deepen its Hunua Quarry, opening access to approximately 225 million tonnes of greywacke. The consent could support more than 50 years of quarry operations, although the announcement does not quantify development costs, timing or financial returns.

Bank of Queensland’s statutory profit rose 88% to $250 million, but underlying cash earnings fell 7% as lending contracted and impairments normalised from a low base. The bank is betting that a completed digital migration, stronger capital position and Challenger partnership can support a return to growth in FY27.

Overwatch Technologies is seeking A$8 million to fund an ASX listing and expand its drone-enabled maritime intelligence business. The company has A$3.8 million of contracted orders, but has yet to recognise revenue and reported an inaugural loss of A$857,604.

Promisia Healthcare has maintained group care occupancy at 96%, above its 95% target, while completing the Chatswood acquisition and preparing to potentially accelerate full ownership of Golden View Village. FY27 underlying EBITDAF guidance of at least $8.0 million remains unchanged for the existing portfolio, with updated guidance due in November.

American Tungsten & Antimony has produced one antimony ingot assaying 99.8% from US-mined material, meeting the highest ASTM B237 grade and exceeding the Regulus II specification. The result comes as the company pursues US government funding and offtake arrangements, although no commitments have been secured and AT4 does not yet control the relevant assets.

Cleo Diagnostics has moved its pre-surgical ovarian cancer test into formal Analytical Validation, a key regulatory step before its planned FDA 510(k) submission in the first half of 2027. The three-batch program is expected to take about three months, but no validation results have yet been reported.

Peninsula Energy’s low-pH uranium restart delivered stronger grades but failed to move enough solution through its Lance wellfields, forcing a guidance withdrawal and a US$50.1 million impairment. The company has fresh funding, but its auditor has warned of material uncertainty over its ability to continue as a going concern.

Ryman Healthcare’s retirement village resales reached an eight-quarter high in the second quarter, while aged care occupancy climbed to 94%. The operating update also shows new-sales inventory continuing to decline as the company positions for stronger recurring earnings.

Inghams Group Limited (ASX:ING) returned to poultry volume growth in FY26, but rising costs, a tax dispute and weaker earnings sharply reduced shareholder returns. The company enters FY27 with lower net debt, elevated leverage and a value-led turnaround strategy still to prove itself.

Aspen Group delivered a sharp rise in FY26 earnings and distributions, then lifted its FY27 targets despite a softer residential sales market. The property group is expanding its affordable rental and development platform, but debt and valuation sensitivity are rising with it.

Lifestyle Communities recorded a sharp slowdown in both new and established home sales in the first quarter, as Victorian downsizers took longer to commit. Net debt fell by $8.4 million, but forthcoming VCAT refund payments will draw on working capital and existing debt facilities.